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Abstract 
Background: Elevation of the immature/total granulocyte (I/T‑G) ratio has been reported after out‑of‑hospital car‑
diac arrest (OHCA). Our purpose here was to evaluate the prognostic significance of the I/T‑G ratio and to investigate 
whether the I/T‑G ratio improves neurological outcome prediction after OHCA.
Methods: This single‑center prospective cohort study included consecutive immunocompetent patients admitted 
to our intensive care unit over a 3‑year period (2012–2014) after successfully resuscitated OHCA. The I/T‑G ratio was 
determined in blood samples collected at admission.
Results: We studied 204 patients (77 % male, median age, 58 [48–67] years), of whom 64 % had a suspected cardiac 
cause of OHCA, 62 % died in the unit, and 31.5 % survived with good cerebral function. Independent outcome predic‑
tors by multivariate analysis were age, first shockable rhythm, bystander‑initiated resuscitation, and I/T‑G ratio. Com‑
pared to the model computed without the I/T‑G ratio, the model with the ratio performed significantly better [areas 
under the ROC curves (AUCs), 0.78 vs. 0.83, respectively; P = 0.04]. These items were used to develop the MyeloScore 
equation: ([0.47 × I/T‑G ratio] + [0.023 × age in years]) − 1.26 if initial VF/VT − 1.1 if bystander‑initiated CPR. The 
MyeloScore predicted neurological outcomes with similar accuracy to the previously reported OHCA score (0.83 and 
0.85, respectively; P = 0.6). The ROC–AUC was 0.84, providing external validation of the MyeloScore.
Conclusions: The I/T‑G ratio independently predicts neurological outcome after OHCA and, when added to other 
known risk factors, improves neurological outcome prediction. The clinical performance of the MyeloScore requires 
evaluation in a prospective study.
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Background
Out-of-hospital cardiac arrest (OHCA) is a major cause 
of death in Western countries with yearly estimates of 
235,000–325,000 in the USA and 350,000–700,000 in 
Europe [1, 2]. Among patients who recover spontaneous 
circulation after an OHCA, very few survive with suffi-
cient neurological function to ensure self-sufficiency [3]. 
Predicting the neurological outcome of patients who are 
comatose after an OHCA therefore has major ethical 
and socioeconomic implications [4] yet is an extraordi-
narily challenging task. Several clinical, laboratory, and 
electrophysiological risk factors have been identified [5]. 
Nevertheless, an accurate assessment of the neurologi-
cal prognosis is usually possible only after several days 
in the intensive care unit (ICU). In most patients, the 
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neurological prognosis cannot be assessed accurately 
until several days after admission to the intensive care 
unit (ICU).
The systemic inflammatory response syndrome (SIRS) 
initially described in patients with sepsis also develops 
after successfully resuscitated cardiac arrest. One fea-
ture of SIRS is elevation of the immature/total granulo-
cyte (I/T-G) ratio, which is associated with mortality in 
both neonates and adults with sepsis [6, 7]. In a recent 
prospective observational study, we documented I/T-G 
elevation after OHCA and showed that this feature was 
associated with postcardiac arrest syndrome (PCAS) and 
ICU mortality [8].
The main objective of this single-center prospective 
cohort study was to evaluate the performance of I/T-G 
in predicting neurological outcomes after OHCA. The 
secondary objective was to develop a score for improving 
the early accurate prediction of neurological outcomes.
Methods
The study was approved by the our institutional review 
board (Comité de Protection des Personnes Nord-Ouest), 
which waived the requirement for written informed con-
sent, as all study procedures were either components of 
standard care or involved minimal risk to the patients. 
Nevertheless, oral informed consent was obtained from 
each patient or next of kin.
Patients
We prospectively included consecutive adults (>18 years) 
admitted to the medical ICU of the University Hospi-
tal, in Caen, France, between June 2012 and November 
2014, with successfully resuscitated OHCA. Patients 
were included if they presented a stable return to spon-
taneous circulation (ROSC). Some of these patients were 
also included in a previously published study (130/204 
patients) [8]. We excluded pregnant women and patients 
with immunosuppression (hematological malignancies, 
solid-organ or bone marrow transplant recipients, leuko-
cyte count <1 × 109/L, corticosteroids in a daily dosage 
>0.5 mg/kg of prednisone-equivalent, or other immuno-
suppressants), and patients with refractory cardiac arrest.
For external validation, we used patients with OHCA 
admitted to the Cochin University Hospital in Paris, 
France, between January 1, 2014, and December 31, 2015.
Care of patients with OHCA
All patients with a sustained return to spontaneous cir-
culation (ROSC) after OHCA were admitted to our ICU 
for management according to our standard protocol, 
which included close monitoring, hemodynamic sup-
port, mechanical ventilation, and analgesia/sedation. 
Briefly, emergency coronary angiography was performed 
whenever a cardiac etiology could not be ruled out. Ther-
apeutic hypothermia (TH) was used in all patients with 
initial ventricular fibrillation (VF) or ventricular tachy-
cardia (VT) [9] and in those patients with initial pulseless 
electric activity (PEA) or asystole who had a suspected 
cardiac etiology or were expected by the physicians to 
have good outcomes. TH with a target temperature of 
33–34 °C was induced then maintained for 12–24 h using 
an endovascular cooling catheter (Icy™ Catheter; Alsius, 
Irvine, CA, USA). During TH, the patients received 
adjusted midazolam and sufentanil dosages for sedation, 
combined with atracurium. Sedation was stopped at TH 
discontinuation in patients without shock or other com-
plications or, in patients not managed with TH, at ICU 
admission. After TH, the target rewarming rate was 
0.5 °C/h and the target temperature was 37 °C.
Neurological function was assessed by daily clinical 
neurological examinations and, between day 2 and day 4, 
by serum neuron-specific enolase (NSE) measurements, 
electroencephalography (EEG), and cortical somatosen-
sory evoked potential (SSEP) recordings. Electrophysi-
ological tests were performed without sedation and, in 
patients who received TH, after rewarming. In patients 
with bilateral absence of cortical SSEPs (N20) [10], fur-
ther treatment was considered futile, and active care 
was withdrawn. In addition, in accordance with previous 
reports [5, 11, 12], for patients with at least three adverse 
prognostic factors after 72  h, withdrawal of active 
care was discussed at a staff meeting held 5  days after 
ICU admission. These adverse prognostic factors were 
absence of pupillary light reflexes or corneal reflexes, 
extensor posturing or no motor responses to painful 
stimulation, persistent myoclonus [13], serum NSE eleva-
tion [14], and a malignant EEG pattern [15].
Immature granulocyte counts
Each included patient had a blood sample drawn at ICU 
admission for blood cell counts and automated analysis 
of leukocyte differentials using the XE-2100 system (Sys-
mex, Kobe, Japan). The immature granulocyte population 
was composed of promyelocytes, myelocytes, and meta-
myelocytes, but not blasts. As described elsewhere [16], 
a lysing reagent was used to lyse the erythrocytes and to 
create ultramicroscopic pores in the leukocyte cell mem-
branes that allowed the entry of a polymethine dye with 
high affinity for nucleic acids. The leukocytes were then 
analyzed based on nucleic-acid fluorescence and side 
scatter [17].
Data collection
The following data were collected prospectively for each 
patient, according to the Utstein style [18]: demograph-
ics, cause of OHCA, initial heart rhythm, time from 
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collapse to basic life support (no-flow time) and from 
basic life support to ROSC (low-flow time), Simplified 
Acute Physiology Score II (SAPS II) [19] and Sequential 
Organ Failure Assessment (SOFA) score [20] on day 1, 
laboratory findings at ICU admission, ICU mortality, and 
cause of death. The OHCA score was calculated for each 
patient as follows [21]: [−13 if the initial recorded rhythm 
is VF or VT] + [6 × ln(no-flow time)] + [9 × ln(low-flow 
time)]  −  [1434/(serum creatinine)]  +  [10  ×  ln(arterial 
lactate)]. The CAHP score was calculated based on the 
previously published nomogram [22]. Postresuscitation 
shock was defined as a need for intravenous vasoactive 
therapy (epinephrine or norepinephrine) for more than 
6 h after ROSC despite adequate fluid loading.
Neurological outcome assessment
The primary evaluation criterion was the cerebral per-
formance category (CPC) at hospital discharge. For this 
study, we defined a good neurological outcome as CPC 1 
or 2, that is, alive with good cerebral performance (CPC 
1) or sufficient cerebral function for independent activi-
ties of daily living, with or without mild neurological or 
psychological deficits (CPC 2). CPC scores 3–5, that is, 
severe cerebral disability (CPC 3), coma or vegetative 
state (CPC 4), and death (CPC 5), were defined as a poor 
neurological outcome.
Statistical analysis
Quantitative variables were described as mean and 
standard deviation if normally distributed and as median 
[25th–75th percentiles] otherwise. Qualitative variables 
were described as n (%). To compare the two groups 
(good [CPC 1–2] and poor [CPC 3–5] neurological out-
come at hospital discharge), we used Student’s t test for 
means, the Mann–Whitney U test for medians, and the 
Chi-square test (or Fisher’s exact test when the sample 
was small) for percentages.
We first performed a univariate analysis to identify 
patient characteristics at ICU admission that were associ-
ated with a good neurological outcome. These variables 
were then selected in a multivariate logistic regression 
via a stepwise procedure to build a multivariate model 
designed to identify factors independently and signifi-
cantly associated with good neurological outcome. The 
odds ratios (ORs) and adjusted ORs (aORs) were com-
puted with their 95 % confidence intervals (95 % CIs).
Maximum-likelihood estimation was then performed 
to analyze all factors available on ICU admission and 
significantly associated with the neurological outcome 
in the multivariate model, and the results were used to 
develop a predictive score (the MyeloScore). The receiver 
operating characteristics (ROC) curve of this score 
was plotted and the area under the curve (AUC–ROC) 
computed (c-index) to assess performance in predicting 
the neurological outcome.
We used SAS version 15.0 (Chicago, IL, USA) for data 
analysis. All tests were two-sided, and P values <0.05 
were considered statistically significant.
Results
Patient characteristics
Of the 214 OHCA survivors admitted to our ICU during 
the 3-year study period, 6 died early after admission, 4 of 
them had cardiac arrest recurrence, and 2 of them pre-
sented a refractory postcardiac arrest shock (n = 2). All 
of them died at the admission to ICU, before blood sam-
ples were drawn. Four had immune deficiencies (immu-
nosuppressants in 3 and hematological malignancy in 1). 
These patients were not included in the analysis. Thus, 
204 patients were studied (Fig. 1). Their main character-
istics are listed in Table 1.
The patients were predominantly male (n = 156, 77 %). 
A cardiac cause was identified in 130 (64  %) patients. 
Noncardiac causes were respiratory (n  =  26), hang-
ing (n  =  18), neurological (n  =  6), and miscellaneous 
(n  =  24). Coronary angiography was performed in 131 
(64  %) patients, and angioplasty in 62 (30  %). TH was 
induced in 85/91 (93 %) patients with VF/VT and 45/113 
(40  %) patients with PEA/asystole. The ICU mortality 
rate was 62 % (126 patients).
Risk factors associated with a poor neurological outcome 
(CPC 3–5)
Of the 204 patients, 64 (31.5 %) were CPC 1 or 2 at hos-
pital discharge. Table 2 reports the variables significantly 
associated with a good neurological outcome by uni-
variate analysis. Those available at ICU admission were 
younger age, cardiac arrest in a public place, witnessed 
arrest, bystander-initiated CPR, and on-scene epineph-
rine therapy. Laboratory variables associated with a good 
neurological outcome were lower values for arterial lac-
tate, creatinine, and I/T-G. The ROC–AUC for hospital 
neurological outcome prediction of I/T-G ratio was 0.75 
[0.68–0.82].
Variables independently associated with a good neu-
rological outcome by multivariable logistic regression 
were younger age, initial VF/VT, bystander-initiated car-




The equation for computing the MyeloScore based on 
variables available at ICU admission and independently 
associated with the neurological outcome at hospital dis-
charge was as follows:
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As shown in Fig. 2a, the ROC–AUC of the multivari-
ate model described above performed significantly bet-
ter than the same model without I/T-G in predicting the 
neurological outcome at hospital discharge (ROC–AUC, 
0.83 vs. 0.78; P = 0.04). Thus, adding I/T-G to established 
risk factors improved the ability to discriminate between 
patients with and without good neurological outcomes.
The MyeloScore performed similarly to the previously 
reported OHCA score in terms of predicting a good neu-
rological outcome (CPC 1 or 2) at hospital discharge [21]. 
However, a significant difference was noted between the 
(
[0.47× I/T-G ratio]+ [0.023× Age in years]
)
− 1.26 if initial VF/VT
− 1.1 if bystander - initiated CPR
MyeloScore and the CAHP score (ROC–AUC, 0.83 vs. 
0.77; P = 0.02) (Fig. 2b).
The optimal cutoff value determined using the Yuden 
index was 1.044, and the sensitivity and specificity of the 
MyeloScore were 62.8 and 92.2 %, respectively.
MyeloScore validation
During the 2-year study period, 253 patients with OHCA 
were admitted to the medical ICU of the Cochin Uni-
versity Hospital. The I/T-G ratio at admission was avail-
able for 216 of these patients, who served for a validation 
study (Table 4). The ROC curve was plotted to assess the 
ability of the MyeloScore to separate patients with and 
without good neurological outcomes. The ROC–AUC 
was 0.84 [0.79–0.89], indicating good performance.
2011-2013
about 750 paents  with 
a
empted resuscitaon aer OHCA
214 paents admi
ed to the ICU
204 paents included in the study
6 paents died early*
4 paents had exclusion criteria:
-1 hematological malignancy
-3 immunosuppressive treatment
64 paents were CPC 1/2 at
hospital discharge
140 paents were CPC 3/5 at
hospital discharge 
Populaon served by the medical first-responder system
about 1 500 000
Fig. 1 Study flowchart. *6 died early after admission, 4 of them had cardiac arrest recurrence, and 2 of them presented a refractory postcardiac 
arrest shock (n = 2). All of them died at the admission to ICU, before blood samples were drawn. These patients were not included in the analysis
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Discussion
The identification of biomarkers that predict the neu-
rological outcome of successfully resuscitated OHCA is 
Table 1 Baseline characteristics of  the patients included 
in the development cohort
Data are expressed in median [IQR] and n (%)
No-flow time is the time between collapse and base life support. Low-flow time 
is the time between base life support and return of spontaneous circulation
CPC cerebral performance category OHCA out-of-hospital cardiac arrest, 
CPR cardiopulmonary resuscitation, VF/VT ventricular fibrillation/ventricular 
tachycardia, PEA pulseless electrical activity, I/T-G ratio of immature over total 
granulocytes in peripheral blood, SOFA Sequential Organ Failure Assessment, 
SAPS II, Simplified Acute Physiology Score version II
Variable All patients (n = 204)
Patient demographics
Age (years) 58 [48–67]
Male sex, n (%) 156 (76.5)
Body mass index (kg/m2) 26 [23–28]
Charlson comorbidity index 0 [0–1]
OHCA characteristics
Location of OHCA, n (%)
Public place 65 (32)
Private place 139 (68)
Witnessed OHCA, n (%) 168 (82.5)
Bystander CPR, n (%) 110 (54)
Arrest rhythm, n (%)
Initial VF/VT 91 (44.6)
PEA/asystole 113 (55.5)
No‑flow time (min) 4 [0–10]
Low‑flow time (min) 20 [15–30]
On‑scene epinephrine dose (mg) 2 [1–5]
Laboratory values at ICU admission
Arterial lactate (mmol/L) 4 [2–7.5]
Creatinine (µmol/L) 103 [84–142]
Troponin (µg/L) 1 [0–11]
Leukocytes (g/L) 15 [11–19.5]
Neutrophils (g/L) 12 [8–16]
I/T‑G ratio (%) 0.9 [0.5–2]
Severity scores
SOFA on day 1 11 [8–13]
SAPS II on day 1 69.5 [59–80]
OHCA score 29.5 [6.5–43.5]
CAHP score 170 [142–200]
Hospital data
Admission temperature (°C) 35 [34–35.5]
Therapeutic hypothermia, n (%) 130 (63)
Early coronary angioplasty, n (%) 62 (30.5)
Postresuscitation shock, n (%) 107 (52.5)
Hospital length of stay (days) 8 [3–17]
Table 2 Univariate analysis of factors associated with out-
come at  hospital discharge after  out-of-hospital cardiac 
arrest
Data are expressed in median [IQR] and n (%)
No-flow time is the time between collapse and base life support. Low-flow time 
is the time between base life support and return of spontaneous circulation
CPC cerebral performance category, OHCA out-of-hospital cardiac arrest, 
CPR cardiopulmonary resuscitation, VF/VT ventricular fibrillation/ventricular 
tachycardia, PEA pulseless electrical activity, I/T-G ratio of immature over total 
granulocytes in peripheral blood, SOFA Sequential Organ Failure Assessment, 
SAPS II Simplified Acute Physiology Score version II






Age (years) 61 [48–69] 53 [46–62] 0.02
Male sex, n (%) 102 (73) 54 (84.5) 0.14
Body mass index (kg/m2) 25.5 [22–29.5] 26.4 [23.1–28] 0.71
Charlson comorbidity index 1 [0–1] 0 [0–1] 0.31
OHCA characteristics
Location of OHCA, n (%) 0.005
Public place 36 (26) 29 (45.5)
Private place 104 (74) 35 (54.5)
Witnessed OHCA, n (%) 109 (78) 59 (92) 0.02
Bystander CPR, n (%) 60 (43) 50 (78) <0.001
Arrest rhythm, n (%) <0.001
Initial VF/VT 47 (33.5) 44 (69)
PEA/asystole 93 (66.5) 20 (31)
No‑flow time (min) 6 [1–10.5] 0 [0–1] <0.001
Low‑flow time (min) 23 [15–30.5] 16 [10–25] 0.003
On‑scene epinephrine  
dose (mg)
3 [1.5–5] 1 [0–3] <0.001
Laboratory values at ICU 
admission
Arterial lactate (mmol/L) 5 [2.5–8.4] 2 [1.5–4.3] <0.001
Creatinine (µmol/L) 113 [90–149] 92 [75–111] <0.001
Troponin (µg/L) 0.8 [0.1–8] 1.7 [0.3–16] 0.07
Leukocytes (g/L) 14.5 [11–19.5] 15 [11.5–20] 0.53
Neutrophils (g/L) 11.5 [8–15] 13 [9–17] 0.15
I/T‑G ratio (%) 1.5 [0.5–2.5] 0.5 [0.3–0.9] <0.001
Severity scores
SOFA on day 1 11 [8.5–14] 9.5 [7–11] 0.001
SAPS II on day 1 74 [61–85] 63.5 [50–72] <0.001
OHCA score 38.5 [22–46] 5 [–3–18 <0.001
CAHP score 184.5 [156–210] 144 [113–165] <0.001
Hospital data
Admission temperature (°C) 35 [34–35.5] 35 [34.5–36] 0.20
Therapeutic hypothermia, 
n (%)
75 (53.5) 55 (86) <0.001
Early coronary angioplasty, 
n (%)
29 (20.5) 33 (51.5) 0.003
Postresuscitation shock, n (%) 79 (56.5) 28 (44) 0.09
Hospital length of stay (days) 5 [3–9] 16 [12–21] <0.001
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an area of active investigation. A few such biomarkers 
have been shown to perform well and are now used rou-
tinely, although they are helpful only several days after 
ROSC. We have reported that a high I/T-G ratio at ICU 
admission predicted ICU mortality after OHCA [8], and 
another group has confirmed this finding [23]. Here, in 
a large prospective cohort of patients after OHCA, we 
demonstrated that a higher I/T-G ratio at ICU admis-
sion independently predicted severe disability or death 
(CPC 3–5). Moreover, the admission I/T-G ratio pro-
vided prognostic information over and above that given 
by three previously established risk factors, namely age, 
VF/VT as the initial recorded rhythm, and bystander-
initiated CPR. The MyeloScore based on all four factors 
performed well in discriminating between patients who 
would and would not survive with good neurological 
function. All the factors used in the MyeloScore are avail-
able at ICU admission.
I/T-G elevation, or granulocyte left shift, indicates an 
increase in circulating immature granulocytes and occurs 
in various acute conditions such as acute hematological 
malignancies, bleeding, and sepsis. An increase in circu-
lating counts of immature granulocytes is a criterion for 
SIRS [24]. In survivors of cardiac arrest, ischemia–rep-
erfusion induces a systemic inflammatory process akin 
to SIRS [25]. This early inflammatory response is often 
accompanied with a combination of circulatory dys-
function and anoxic brain injury known as postcardiac 
arrest syndrome (PCAS) [3]. Immature neutrophils enter 
the circulation early in the course of PCAS. The release 
by the bone marrow of immature granulocytes into the 
circulation may involve a variety of mechanisms such as 
bone marrow ischemia [26], neutrophil paralysis [27], 
and endotoxemia [28]. The finding of I/T-G elevation 
at ICU admission after OHCA argues against a role for 
infection. Furthermore, in our previous study [8], I/T-G 
was not significantly associated with mean arterial pres-
sure at admission, fluid loading during resuscitation, or 
body temperature at admission. Thus, I/T-G elevation 
after OHCA seems to reflect noninfectious systemic 
inflammation.
Most current blood analyzers provide the count of 
immature granulocytes or a similar parameter rou-
tinely, without additional cost. We chose a widely used 
automated blood analyzer (XE 2100) to evaluate blood 
cell counts and I/T-G. Studies have established that 
Table 3 Multivariable analysis: independent predictors 
of outcome at hospital discharge after out-of-hospital car-
diac arrest
c-index of the model, 0.83; goodness-of-fit (Hosmer–Lemeshow) Chi-square P 
value, 0.18
ICU intensive care unit, OR odds ratio, 95 % CI 95 % confidence interval, VF/
VT ventricular fibrillation/ventricular tachycardia, CPR cardiopulmonary 
resuscitation, I/T-G ratio of immature over total granulocytes in peripheral blood
Variables at ICU admission OR 95 % CI P value
Age (per year) 0.98 [0.95–1] 0.06
VF/VT as initial rhythm 3.5 [1.7–7.4] <0.001
Bystander‑initiated CPR 3 [1.4–6.4] 0.005
I/T‑G ratio (per 0.1) 0.62 [0.45–0.89] 0.006
1 - Specificity












Myeloscore model without I/T-G ratio, 
AUC = 0.78
Myeloscore, AUC = 0.83
a
1 - Specificity












CAHP score, AUC = 0.77
OHCA score, AUC = 0.85
Myeloscore, AUC = 0.83
b
Fig. 2 a Receiver operating characteristics curves for MyeloScore 
model with and without I/T‑G ratio. b Receiver operating characteris‑
tics curves for MyeloScore, OHCA score, and CAHP score calculated at 
ICU admission
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automated counting is better than manual morphology-
based counting for evaluating numbers of immature 
granulocytes in peripheral blood [29]. Another group 
used the ADVIA 2120 analyzer (Siemens, Forchheim, 
Germany) to determine another marker for granulocyte 
immaturity, known as the delta neutrophil index, which 
was high in OHCA survivors [23]. This index was also 
high in patients with sepsis [6]. Thus, an increase in cir-
culating immature granulocytes may hold prognostic 
value regardless of the parameter used to assess it.
The early prediction of clinical outcomes after OHCA 
is singularly difficult. Most of the available prognostic 
tools can be used only several days after ICU admis-
sion. Furthermore, the use of TH delays the evaluation of 
neurological function [30], increasing the need for prog-
nostic tools that perform well early after cardiac arrest. 
The OHCA score is based solely on variables available 
at ICU admission and predicts severe neurological dis-
ability or death (CPC 3–5) [21]. It was developed and 
validated in several cohorts of patients in Paris, France, 
and then further validated in a prospective cohort study 
conducted in the USA [31]. The OHCA score variables 
are initial shockable rhythm, creatinine, arterial lactate, 
and durations of no-flow and low-flow intervals. These 
variables chiefly reflect the circumstances before and 
during OHCA. They are also the main determinants of 
PCAS severity and are independent from the quality of 
post-OHCA care in the ICU [32]. In our population, the 
OHCA score had an AUC–ROC of 0.85, indicating good 
performance in predicting the short-term neurological 
outcome.
The MyeloScore performed similarly to the OHCA 
score in discriminating between patients who were CPC 
1–2 or CPC 3–5 at hospital discharge. Importantly, add-
ing the I/T-G ratio to age, initial rhythm, and bystander-
initiated CPR significantly improved neurological 
outcome prediction. Three MyeloScore items are rou-
tinely recorded by on-scene healthcare providers, and the 
remaining item, the I/T-G ratio, is obtained at ICU admis-
sion. The durations of the no-flow and low-flow intervals 
are intentionally not included in the MyeloScore, but the 
effects of these two variables are probably reflected by the 
I/T-G ratio and bystander-initiated CPR. Furthermore, 
data on no-flow and low-flow durations are often inac-
curate, and when the arrest is unwitnessed, the no-flow 
interval is unknown and the OHCA cannot be computed. 
To minimize the impact of inaccuracies in no-flow and 
low-flow data, logarithmic transformations of these two 
variables are used, making computation of the OHCA 
score more complex. In addition, two other OHCA 
items, serum creatinine and lactate levels, can be affected 
not only by OHCA-related ischemia–reperfusion, but 
also by preexisting disease such as renal failure or cirrho-
sis. In our cohort, the CAHP score performed less well 
than the MyeloScore and OHCA score in predicting out-
comes. The CAHP score was developed and validated in 
large cohorts but may suffer from inaccuracies related to 
the use of a nomogram as opposed to an equation for its 
computation.
Although scores can contribute to predict neuro-
logical outcomes, they provide probabilities and, there-
fore, cannot serve to make treatment decisions for the 
individual patient. Instead, neuroprognostication after 
OHCA should rely on a range of clinical, biological, and 
neurophysiological tests [33]. A poor score value consid-
ered alone cannot justify treatment limitation decisions. 
It can, however, be added to the many other available 
predictors, to help adjust the management strategy and 
anticipate the patient’s needs.
One limitation of our study is the single-center design, 
which may affect the general applicability of our findings. 
Furthermore, we did not assess the immune properties 
of the immature granulocytes. Our study merely indi-
cates an association between a higher proportion of cir-
culating immature granulocytes and a poorer outcome of 
OHCA. Whether immature granulocytes are involved in 
the pathogenesis of PCAS remains to be investigated. In 
sepsis, immature granulocytes seem to perform nearly as 
well as mature neutrophils in mediating innate immune 
functions [34]. Moreover, as in the OHCA score studies, 
the primary outcome in our study was the short-term 
CPC, at hospital discharge. Long-term CPC was not 
assessed. Nevertheless, in recent work, CPC at hospital 
discharge reflected long-term survival and seemed to 
hold promise for program evaluation and resuscitation 
research [35]. Last, we did not assess the I/T-G ratio at 
specific time points after admission. However, when 
developing the study protocol, we looked at I/T-G ratio 
values obtained routinely on the day after ICU admission 
(data not shown). At this time point, often more than 
12  h after ROSC, the I/T-G ratio was consistently low 
(between 0.2 and 0.5 %), even in patients with poor out-
comes. Thus, the I/T-G ratio determined later than in our 
study may not have predictive value.
Table 4 Baseline characteristics of  the 216 patients 
included in the validation cohort (MyeloScore variables)
ICU intensive care unit, OR odds ratio, 95 % CI 95 % confidence interval, VF/
VT ventricular fibrillation/ventricular tachycardia, CPR cardiopulmonary 
resuscitation, I/T-G ratio of immature over total granulocytes in peripheral blood
Variables at ICU admission All patients (n = 216)
Age (years) 65.9 [55.4–76.5]
VF/VT as initial rhythm 115 (53)
Bystander‑initiated CPR, n (%) 144 (66.7)
I/T‑G ratio (%) 1.4 [0.8–3]
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Conclusion
After OHCA, the I/T-G ratio at ICU admission is inde-
pendently associated with the neurological outcome at 
hospital discharge. We used this ratio and three other 
readily available items to develop the MyeloScore, which 
performed well in predicting neurological outcomes. The 
wide availability of I/T-G determination in hospital lab-
oratories may facilitate the use of this marker. Whether 
the MyeloScore can help in risk stratification and, there-
fore, in making treatment decisions deserves to be 
investigated.
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